Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
| ▸ | BACE1 | P56817 | 10/20 | 0.60 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.60 |
| ▸ | CTSD | P07339 | 1/20 | 0.59 |
| ▸ | MME | P08473 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31720977 | 0.99 | LTA4H (0.63) | LTA4HBACE1BACE2CTSDMME | |
| SCHEMBL30903468 | 0.99 | LTA4H (0.63) | LTA4HBACE1BACE2CTSDMME | |
| SCHEMBL27780591 | 0.97 | LTA4H (0.60) | LTA4HBACE1BACE2CTSDMME | |
| SCHEMBL29385423 | 0.95 | LTA4H (0.58) | LTA4HBACE1BACE2CTSDMME | |
| SCHEMBL29499677 | 0.93 | BACE1 (0.68) | LTA4HBACE1BACE2CTSD | |
| SCHEMBL30804672 | 0.92 | BACE1 (0.69) | BACE1BACE2CTSD | |
| SCHEMBL31022699 | 0.92 | BACE1 (0.64) | BACE1BACE2CTSD | |
| SCHEMBL30051506 | 0.92 | LTA4H (0.72) | LTA4HMME | |
| SCHEMBL29425531 | 0.91 | BACE1 (0.64) | BACE1BACE2CTSD | |
| SCHEMBL30544311 | 0.91 | LTA4H (0.62) | LTA4HBACE1BACE2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163482-A1 | NOVEL SYNTHETIC PROMOTER, AND METHOD FOR PRODUCING DAPTOMYCIN USING SAME | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2025-05-22 | — | — | US | disclosed |
| CN-113583983-B | Fusion protein or variant thereof and application thereof in preparing calcitol | 弈柯莱生物科技(集团)股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-115335526-B | Ribozyme-mediated RNA assembly and expression | 罗切斯特大学 | 2025-04-18 | — | — | CN | disclosed |
| CN-110945120-B | Determination of potency of receptor-ligand interactions in nanomedicines | 优迪有限合伙公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-112740044-B | Method for diagnosis or prognosis of neurological disorders | 阿尔斯特创新有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-115851811-B | Application of receptor kinase PXY in controlling plant bud regeneration | 陕西师范大学 | 2025-04-01 | — | — | CN | disclosed |
| CN-115247191-B | Gene editing system and application thereof in construction of double-gene mutated nevus basal cell carcinoma syndrome pig nuclear transfer donor cells | 南京启真基因工程有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-111629786-B | Compositions and methods for editing RNA | 俄勒冈健康与科学大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-112789505-B | Biosynthetic platforms for the production of cannabinoids and other prenylated compounds | 加利福尼亚大学董事会 | 2024-04-09 | — | — | CN | disclosed |
| CN-117677846-A | Method for measuring protein C and activated protein C | 生物医学网络研究财团中心(CIBER) | 2024-03-08 | — | — | CN | disclosed |
| CN-115243713-A | Methods and compositions for delivering modified lymphocyte aggregates | 埃克苏马生物技术公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-115175929-A | BCMA CAR-T cells with enhanced activity | 艾洛基治疗公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-115136009-A | Biomarkers for diagnosis of respiratory tract infections | B.R.A.H.M.S有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-108779457-B | Gene involved in synthesis of tetrodotoxin, dihydrotetrodotoxin or tetrodotoxin production method using same, and transformant containing same | 组合化学工业株式会社 | 2022-09-13 | — | — | CN | disclosed |
| CN-114732896-B | Application of skeletal muscle secretion factor Thbs4 in preparation of medicine for improving systemic glycolipid metabolism | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2022-09-02 | — | — | CN | disclosed |
| CN-111018999-B | Dimeric immune fusion protein, pharmaceutical composition and use | 沣潮医药科技（上海）有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114732896-A | Application of skeletal muscle secretion factor Thbs4 in preparation of medicine for improving systemic glycolipid metabolism | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2022-07-12 | — | — | CN | disclosed |
| CN-114302741-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2022-04-08 | — | — | CN | disclosed |
| CN-114072677-A | Reagents and methods for cancer detection, prognosis and therapy monitoring | 美国桑福德医疗集团 | 2022-02-18 | — | — | CN | disclosed |
| CN-107406864-B | Method for producing L-serine using genetically engineered microorganisms lacking serine degradation pathway | 化学生物有限公司 | 2022-02-11 | — | — | CN | disclosed |